Femasys FEMY
NASDAQ FEMY
$2.83 +0.15 (+5.60%)
At close: Sep 9, 2026 · 4:00 PM EDT

Femasys (FEMY) Non-Current Assets (2020 - 2026)

Femasys' (FEMY) quarterly Non-Current Assets came in at $2.1 million in Q2 2026, down 13.63% on a YoY basis from $2.4 million in Q2 2025, and down 5.8% quarter-over-quarter from $2.2 million in Q1 2026.

Analysis

Femasys (FEMY) Non-Current Assets (2020 - 2026) Analysis & Trends

Femasys (FEMY) has reported Non-Current Assets for 7 consecutive years, with $2.1 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non-Current Assets fell 13.63% year-over-year to $2.1 million; the trailing twelve-month figure through Jun 2026 stood at $2.1 million (down 13.63% YoY), and the FY2025 full-year result was $2.4 million, down 16.07% from the prior year.
  • Non-Current Assets slipped to $2.1 million in Q2 2026 per FEMY's latest filing, from $2.2 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $3.5 million in Q3 2023 and bottomed at $1.0 million in Q2 2023.
  • Historically, Non-Current Assets has averaged $2.2 million across 5 years, with a median of $2.3 million in 2025.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Assets soared 199.68% in 2024, then declined 21.49% in 2025.
  • Over 5 years, Non-Current Assets stood at $1.3 million in 2022, then surged by 170.63% to $3.5 million in 2023, then declined by 18.47% to $2.8 million in 2024, then decreased by 16.07% to $2.4 million in 2025, then declined by 11.54% to $2.1 million in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $2.1 million, $2.2 million, and $2.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn 84.70 Bn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn 11.33 Bn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn 68.92 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn 33.51 Bn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn 37.24 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn 7.05 Bn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn 24.47 Bn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 2.37 Bn
9 Steris 21.90 Bn 21.43 Bn 684.20 Mn 8.29 Bn
10 Femasys 9.01 Mn 7.57 Mn 189,391.00 2.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.10 Mn
Mar 31, 2026 2.23 Mn
Dec 31, 2025 2.37 Mn
Sep 30, 2025 2.29 Mn
Jun 30, 2025 2.43 Mn
Mar 31, 2025 2.57 Mn
Dec 31, 2024 2.83 Mn
Sep 30, 2024 2.90 Mn
Jun 30, 2024 3.08 Mn
Mar 31, 2024 3.27 Mn
Dec 31, 2023 3.47 Mn
Sep 30, 2023 3.47 Mn
Jun 30, 2023 1.03 Mn
Mar 31, 2023 1.16 Mn
Dec 31, 2022 1.28 Mn
Sep 30, 2022 1.20 Mn
Jun 30, 2022 1.16 Mn
Mar 31, 2022 1.22 Mn
Dec 31, 2021 1.35 Mn
Sep 30, 2021 1.22 Mn